专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US07438909B2 Immunization and treatment methods for anthrax 失效
标题翻译：炭疽的免疫和治疗方法
公开(公告)号：US07438909B2
公开(公告)日：2008-10-21
申请号：US11041763
申请日：2005-01-24
申请人： Jeanne Morrow, legal representative , Angray S. Kang , Fei Wang , Ivy Jiang , Ritsuko Sawada , Wolfgang Scholz
发明人： Phillip R. Morrow
IPC分类号： A61K39/395 , A61K39/40
CPC分类号： C07K16/1278 , A61K39/40 , A61K2039/505 , C07K2317/21 , C07K2317/56 , C07K2317/76 , C07K2317/92 , A61K2300/00
摘要： A highly efficient method for generating human antibodies using recall technology is provided. In one aspect, human antibodies which are specific to the anthrax toxin are provided. In one aspect, human peripheral blood cells that have been pre-exposed to anthrax toxin are used in the SCID mouse model. This method results in high human antibody titers which are primarily of the IgG isotype and which contain antibodies of high specificity and affinity to desired antigens. The antibodies generated by this method can be used therapeutically and prophylactically for preventing or treating mammals exposed to anthrax. Thus, in one embodiment, a prophylactic or therapeutic agent used to counter the effects of anthrax toxin, released as a mechanism of bioterrorism, is provided. In one embodiment, a formulation and method for preventing and/or treating anthrax infection comprising a binding agent that prevents the assembly of the PA63 heptamer is also provided. Methods for diagnosis and methods to determine anthrax contamination are also described.
摘要翻译：提供了使用召回技术产生人抗体的高效方法。一方面，提供了对炭疽毒素特异性的人抗体。一方面，在SCID小鼠模型中使用预先暴露于炭疽毒素的人外周血细胞。该方法导致高的人抗体滴度，其主要是IgG同种型，并且其含有对所需抗原具有高特异性和亲和力的抗体。通过该方法产生的抗体可以治疗和预防用于预防或治疗暴露于炭疽的哺乳动物。因此，在一个实施方案中，提供了用作抵抗作为生物恐怖机制的机制释放的炭疽毒素的作用的预防或治疗剂。在一个实施方案中，还提供了用于预防和/或治疗炭疽感染的制剂和方法，其包含防止PA63七聚体组装的结合剂。还描述了诊断方法和确定炭疽污染的方法。

2. 发明授权

US07442373B2 Antibodies against protective antigen and methods of use for passive immunization and treatment of anthrax 失效
标题翻译：针对保护性抗原的抗体和用于被动免疫和治疗炭疽的方法
公开(公告)号：US07442373B2
公开(公告)日：2008-10-28
申请号：US11041318
申请日：2005-01-24
申请人： Jeanne Morrow, legal representative , Angray S. Kang , Fei Wang , Ivy Jiang , Ritsuko Sawada , Wolfgang Scholz
发明人： Phillip R. Morrow
IPC分类号： C07K16/00 , C12P21/08
CPC分类号： C07K16/1278 , A61K39/40 , A61K2039/505 , C07K2317/21 , C07K2317/56 , C07K2317/76 , C07K2317/92 , A61K2300/00
摘要： A highly efficient method for generating human antibodies using recall technology is provided. In one aspect, human antibodies which are specific to the anthrax toxin are provided. In one aspect, human peripheral blood cells that have been pre-exposed to anthrax toxin are used in the SCID mouse model. This method results in high human antibody titers which are primarily of the IgG isotype and which contain antibodies of high specificity and affinity to desired antigens. The antibodies generated by this method can be used therapeutically and prophylactically for preventing or treating mammals exposed to anthrax. Thus, in one embodiment, a prophylactic or therapeutic agent used to counter the effects of anthrax toxin, released as a mechanism of bioterrorism, is provided. In one embodiment, a formulation and method for preventing and/or treating anthrax infection comprising a binding agent that prevents the assembly of the PA63 heptamer is also provided. Methods for diagnosis and methods to determine anthrax contamination are also described.
摘要翻译：提供了使用召回技术产生人抗体的高效方法。一方面，提供了对炭疽毒素特异性的人抗体。一方面，在SCID小鼠模型中使用预先暴露于炭疽毒素的人外周血细胞。该方法导致高的人抗体滴度，其主要是IgG同种型，并且其含有对所需抗原具有高特异性和亲和力的抗体。通过该方法产生的抗体可以治疗和预防用于预防或治疗暴露于炭疽的哺乳动物。因此，在一个实施方案中，提供了用作抵抗作为生物恐怖机制的机制释放的炭疽毒素的作用的预防或治疗剂。在一个实施方案中，还提供了用于预防和/或治疗炭疽感染的制剂和方法，其包含防止PA63七聚体组装的结合剂。还描述了诊断方法和确定炭疽污染的方法。

3. 发明申请

US20060246079A1 Neutralizing human antibodies to anthrax toxin 审中-公开
标题翻译：中和人类抗体对炭疽毒素
公开(公告)号：US20060246079A1
公开(公告)日：2006-11-02
申请号：US11040580
申请日：2005-01-21
申请人： Phillip Morrow , Jeanne Morrow , Angray Kang , Fei Wang , Ivy Jiang , Ritsuko Sawada , Wolfgang Scholz
发明人： Phillip Morrow , Jeanne Morrow , Angray Kang , Fei Wang , Ivy Jiang , Ritsuko Sawada , Wolfgang Scholz
IPC分类号： A61K39/40 , C07K16/12
CPC分类号： C07K16/1278 , A61K39/40 , A61K2039/505 , C07K2317/21 , C07K2317/56 , C07K2317/76 , C07K2317/92 , A61K2300/00
摘要： A highly efficient method for generating human antibodies using recall technology is provided. In one aspect, human antibodies which are specific to the anthrax toxin are provided. In one aspect, human peripheral blood cells that have been pre-exposed to anthrax toxin are used in the SCID mouse model. This method results in high human antibody titers which are primarily of the IgG isotype and which contain antibodies of high specificity and affinity to desired antigens. The antibodies generated by this method can be used therapeutically and prophylactically for preventing or treating mammals exposed to anthrax. Thus, in one embodiment, a prophylactic or therapeutic agent used to counter the effects of anthrax toxin, released as a mechanism of bioterrorism, is provided. In one embodiment, a formulation and method for preventing and/or treating anthrax infection comprising a binding agent that prevents the assembly of the PA63 heptamer is also provided. Methods for diagnosis and methods to determine anthrax contamination are also described.
摘要翻译：提供了使用召回技术产生人抗体的高效方法。一方面，提供了对炭疽毒素特异性的人抗体。一方面，在SCID小鼠模型中使用预先暴露于炭疽毒素的人外周血细胞。该方法导致高的人抗体滴度，其主要是IgG同种型，并且其含有对所需抗原具有高特异性和亲和力的抗体。通过该方法产生的抗体可以治疗和预防用于预防或治疗暴露于炭疽的哺乳动物。因此，在一个实施方案中，提供了用作抵抗作为生物恐怖机制的机制释放的炭疽毒素的作用的预防或治疗剂。在一个实施方案中，还提供了用于预防和/或治疗炭疽感染的制剂和方法，其包含防止PA63七聚体组装的结合剂。还描述了诊断方法和确定炭疽污染的方法。

4. 发明申请

US20080063647A1 Antibodies against protective antigen and methods of use for passive immunization and treatment of anthrax 失效
标题翻译：针对保护性抗原的抗体和用于被动免疫和治疗炭疽的方法
公开(公告)号：US20080063647A1
公开(公告)日：2008-03-13
申请号：US11041318
申请日：2005-01-24
申请人： Phillip R. Morrow , Angray S. Kang , Fei Wang , Ivy Jiang , Ritsuko Sawada , Wolfgang Scholz , Jeanne Morrow
发明人： Phillip R. Morrow , Angray S. Kang , Fei Wang , Ivy Jiang , Ritsuko Sawada , Wolfgang Scholz , Jeanne Morrow
IPC分类号： A61K39/40 , C07K16/12
CPC分类号： C07K16/1278 , A61K39/40 , A61K2039/505 , C07K2317/21 , C07K2317/56 , C07K2317/76 , C07K2317/92 , A61K2300/00
摘要： A highly efficient method for generating human antibodies using recall technology is provided. In one aspect, human antibodies which are specific to the anthrax toxin are provided. In one aspect, human peripheral blood cells that have been pre-exposed to anthrax toxin are used in the SCID mouse model. This method results in high human antibody titers which are primarily of the IgG isotype and which contain antibodies of high specificity and affinity to desired antigens. The antibodies generated by this method can be used therapeutically and prophylactically for preventing or treating mammals exposed to anthrax. Thus, in one embodiment, a prophylactic or therapeutic agent used to counter the effects of anthrax toxin, released as a mechanism of bioterrorism, is provided. In one embodiment, a formulation and method for preventing and/or treating anthrax infection comprising a binding agent that prevents the assembly of the PA63 heptamer is also provided. Methods for diagnosis and methods to determine anthrax contamination are also described.
摘要翻译：提供了使用召回技术产生人抗体的高效方法。一方面，提供了对炭疽毒素特异性的人抗体。一方面，在SCID小鼠模型中使用预先暴露于炭疽毒素的人外周血细胞。该方法导致高的人抗体滴度，其主要是IgG同种型，并且其含有对所需抗原具有高特异性和亲和力的抗体。通过该方法产生的抗体可以治疗和预防用于预防或治疗暴露于炭疽的哺乳动物。因此，在一个实施方案中，提供了用作抵抗作为生物恐怖机制的机制释放的炭疽毒素的作用的预防或治疗剂。在一个实施方案中，还提供了用于预防和/或治疗炭疽感染的制剂和方法，其包含阻止PA 63七聚体组装的结合剂。还描述了诊断方法和确定炭疽污染的方法。

5. 发明申请

US20090202553A1 Antibodies against anthrax protective antigen 审中-公开
标题翻译：针对炭疽保护性抗原的抗体
公开(公告)号：US20090202553A1
公开(公告)日：2009-08-13
申请号：US12230549
申请日：2008-08-29
申请人： Phillip R. Morrow , Angray S. Kang , Fei Wang , Ivy Jiang , Ritsuko Sawada , Wolfgang Scholz , Jeanne Morrow
发明人： Phillip R. Morrow , Angray S. Kang , Fei Wang , Ivy Jiang , Ritsuko Sawada , Wolfgang Scholz , Jeanne Morrow
IPC分类号： C07K16/12 , C12N15/13 , C12N15/85 , C12N5/10 , C12P21/08 , A61K39/40 , A61P31/04
CPC分类号： C07K16/1278 , A61K39/40 , A61K2039/505 , C07K2317/21 , C07K2317/56 , C07K2317/76 , C07K2317/92 , A61K2300/00
摘要： A highly efficient method for generating human antibodies using recall technology is provided. In one aspect, human antibodies which are specific to the anthrax toxin are provided. In one aspect, human peripheral blood cells that have been pre-exposed to anthrax toxin are used in the SCID mouse model. This method results in high human antibody titers which are primarily of the IgG isotype and which contain antibodies of high specificity and affinity to desired antigens. The antibodies generated by this method can be used therapeutically and prophylactically for preventing or treating mammals exposed to anthrax. Thus, in one embodiment, a prophylactic or therapeutic agent used to counter the effects of anthrax toxin, released as a mechanism of bioterrorism, is provided. In one embodiment, a formulation and method for preventing and/or treating anthrax infection comprising a binding agent that prevents the assembly of the PA63 heptamer is also provided. Methods for diagnosis and methods to determine anthrax contamination are also described.
摘要翻译：提供了使用召回技术产生人抗体的高效方法。一方面，提供了对炭疽毒素特异性的人抗体。一方面，在SCID小鼠模型中使用预先暴露于炭疽毒素的人外周血细胞。该方法导致高的人抗体滴度，其主要是IgG同种型，并且其含有对所需抗原具有高特异性和亲和力的抗体。通过该方法产生的抗体可以治疗和预防用于预防或治疗暴露于炭疽的哺乳动物。因此，在一个实施方案中，提供了用作抵抗作为生物恐怖机制的机制释放的炭疽毒素的作用的预防或治疗剂。在一个实施方案中，还提供了用于预防和/或治疗炭疽感染的制剂和方法，其包含防止PA63七聚体组装的结合剂。还描述了诊断方法和确定炭疽污染的方法。

6. 发明申请

US20080081042A1 Passive Immunization and methods of treament for anthrax using antibodies 失效
标题翻译：被动免疫和使用抗体治疗炭疽的方法
公开(公告)号：US20080081042A1
公开(公告)日：2008-04-03
申请号：US11041763
申请日：2005-01-24
申请人： Phillip R. Morrow , Angray S. Kang , Fei Wang , Ivy Jiang , Ritsuko Sawada , Wolfgang Scholz , Jeanne Morrow
发明人： Phillip R. Morrow , Angray S. Kang , Fei Wang , Ivy Jiang , Ritsuko Sawada , Wolfgang Scholz , Jeanne Morrow
IPC分类号： A61K39/40 , C07K16/12
CPC分类号： C07K16/1278 , A61K39/40 , A61K2039/505 , C07K2317/21 , C07K2317/56 , C07K2317/76 , C07K2317/92 , A61K2300/00
摘要： A highly efficient method for generating human antibodies using recall technology is provided. In one aspect, human antibodies which are specific to the anthrax toxin are provided. In one aspect, human peripheral blood cells that have been pre-exposed to anthrax toxin are used in the SCID mouse model. This method results in high human antibody titers which are primarily of the IgG isotype and which contain antibodies of high specificity and affinity to desired antigens. The antibodies generated by this method can be used therapeutically and prophylactically for preventing or treating mammals exposed to anthrax. Thus, in one embodiment, a prophylactic or therapeutic agent used to counter the effects of anthrax toxin, released as a mechanism of bioterrorism, is provided. In one embodiment, a formulation and method for preventing and/or treating anthrax infection comprising a binding agent that prevents the assembly of the PA63 heptamer is also provided. Methods for diagnosis and methods to determine anthrax contamination are also described.
摘要翻译：提供了使用召回技术产生人抗体的高效方法。一方面，提供了对炭疽毒素特异性的人抗体。一方面，在SCID小鼠模型中使用预先暴露于炭疽毒素的人外周血细胞。该方法导致高的人抗体滴度，其主要是IgG同种型，并且其含有对所需抗原具有高特异性和亲和力的抗体。通过该方法产生的抗体可以治疗和预防用于预防或治疗暴露于炭疽的哺乳动物。因此，在一个实施方案中，提供了用作抵抗作为生物恐怖机制的机制释放的炭疽毒素的作用的预防或治疗剂。在一个实施方案中，还提供了用于预防和/或治疗炭疽感染的制剂和方法，其包含防止PA63七聚体组装的结合剂。还描述了诊断方法和确定炭疽污染的方法。

7. 发明申请

US20050281830A1 Detection, prevention, and treatment systems for anthrax 审中-公开
标题翻译：炭疽检测，预防和治疗系统
公开(公告)号：US20050281830A1
公开(公告)日：2005-12-22
申请号：US11041471
申请日：2005-01-24
申请人： Phillip Morrow , Jeanne Morrow , Angray Kang , Fei Wang , Ivy Jiang , Ritsuko Sawada , Wolfgang Scholz
发明人： Phillip Morrow , Jeanne Morrow , Angray Kang , Fei Wang , Ivy Jiang , Ritsuko Sawada , Wolfgang Scholz
IPC分类号： A61K39/40 , G01N33/554 , G01N33/569
CPC分类号： G01N33/6854 , A61K39/395 , A61K45/06 , A61K2039/505 , A61K2039/507 , C07K16/1278 , C07K2317/21 , G01N2333/35 , A61K2300/00
摘要： A highly efficient method for generating human antibodies using recall technology is provided. In one aspect, human antibodies which are specific to the anthrax toxin are provided. In one aspect, human peripheral blood cells that have been pre-exposed to anthrax toxin are used in the SCID mouse model. This method results in high human antibody titers which are primarily of the IgG isotype and which contain antibodies of high specificity and affinity to desired antigens. The antibodies generated by this method can be used therapeutically and prophylactically for preventing or treating mammals exposed to anthrax. Thus, in one embodiment, a prophylactic or therapeutic agent used to counter the effects of anthrax toxin, released as a mechanism of bioterrorism, is provided. In one embodiment, a formulation and method for preventing and/or treating anthrax infection comprising a binding agent that prevents the assembly of the PA63 heptamer is also provided. Methods for diagnosis and methods to determine anthrax contamination are also described.
摘要翻译：提供了使用召回技术产生人抗体的高效方法。一方面，提供了对炭疽毒素特异性的人抗体。一方面，在SCID小鼠模型中使用预先暴露于炭疽毒素的人外周血细胞。该方法导致高的人抗体滴度，其主要是IgG同种型，并且其含有对所需抗原具有高特异性和亲和力的抗体。通过该方法产生的抗体可以治疗和预防用于预防或治疗暴露于炭疽的哺乳动物。因此，在一个实施方案中，提供了用作抵抗作为生物恐怖机制的机制释放的炭疽毒素的作用的预防或治疗剂。在一个实施方案中，还提供了用于预防和/或治疗炭疽感染的制剂和方法，其包含防止PA63七聚体组装的结合剂。还描述了诊断方法和确定炭疽污染的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式